Category: Intellectual property
-
Bristol-Myers Squibb Licensing Gene Therapies in $2.3B Deal
6 April 2015. Drug maker Bristol-Myers Squibb is licensing gene therapies from biotechnology company uniQure N.V. in a deal with a total potential value of $2.3 billion, including an equity stake in uniQure. The agreement gives Bristol-Myers Squibb exclusive access to as many as 10 disease programs being developed by uniQure, including a treatment for…
-
Astellas Getting First Access to Leukemia Antibody
3 April 2015. MD Anderson Cancer Center in Houston is granting Astellas Pharma Inc. in Tokyo an option to license MD Anderson’s discovery of a synthetic antibody showing promise as a treatment for acute myeloid leukemia. For the licensing option, MD Anderson could earn up to $26 million in fees and research funding. Acute myeloid…
-
Novartis, Aduro Biotech Partner on Cancer Immunotherapy
30 March 2015. The pharmaceutical company Novartis is licensing cancer immunotherapy technology from Aduro Biotech in Berkeley, California. The collaboration could earn Aduro as much as $750 million, including an equity stake, for access to its work on cyclic dinucleotides, still in preclinical study, but considered promising as a cancer treatment. Cyclic dinucleotides are naturally…
-
Lilly Acquiring Treatment for Autoimmune Disorders
19 March 2015. The pharmaceutical company Eli Lilly and Company is acquiring from Hanmi Pharmaceutical, an experimental drug that blocks the actions of an enzyme associated with rheumatoid arthritis and other autoimmune diseases. The deal can pay Hanmi, in Seoul, Korea, as much as $690 million. Autoimmune disorders are diseases where the body’s immune system…
-
UC-Davis Spins Off Irrigation Technology Start-Up
19 March 2015. A graduate student in agriculture at University of California in Davis turned his research on irrigation technology into a new enterprise addressing the chronic drought conditions facing that state’s farmers. Tom Shapland started Tule Technologies Inc. in January 2014 that licensed his research measuring agricultural water use from the university. Tule (pronounced…
-
MedImmune, Joslin Partner on Diabetes Research
10 March 2015. Joslin Diabetes Center in Boston and MedImmune, the biotechnology subsidiary of pharmaceutical company AstraZeneca, are collaborating on research to identify new drugs to treat diabetes. While the partnership calls for MedImmune to fund research conducted at Joslin, financial terms of the deal were not disclosed. Diabetes is a chronic condition where the pancreas…
-
Alliance to Build Photonic Mosquito Control Device
3 March 2015. A collaboration between a social enterprise and lighting technology company aims to develop a laser device to control disease-carrying mosquitoes without pesticides. Financial details of the partnership between Global Good and Lighting Science Group, a designer of advanced industrial and residential lighting systems, were not disclosed. Global Good brings together government, business,…
-
Patent Issued for Mobile Pulse Oximetry Technology
25 February 2015. LionsGate Technologies Inc., a medical device company in Vancouver, Canada, received a patent for techniques and processes that connect sensors measuring blood oxygen levels to smartphones and tablets. Patent number 8,958,859 was issued by U.S. Patent and Trademark Office on 17 February 2015 to inventors Mark Ansermino, LionsGate’s chief medical officer, and…
-
European Patent Issued for Rare Liver Disease Drug
18 February 2015. Synageva BioPharma Corp., a biopharmaceutical company developing therapies for rare diseases, received a European patent on its treatment for lysosomal acid lipase deficiency, an inherited disease causing severe disruptions and injuries to the liver. The European Patent Office issued patent number EP2613798 B1 on 11 February to inventor Anthony Quinn, Synageva’s chief…
-
Patent Awarded for Neurostimulation Electronics
17 February 2015. A U.S. patent on electronic components for switching and pulse generation in neurostimulation devices was awarded earlier this month. The Patent and Trademark Office awarded patent number 8,948,880 on 3 February to Barry Yomtov, founder and chief technologist of AdvaStim Inc. in Beverly, Massachusetts, and assigned to the company. AdvaStim develops modular…